Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2024-01-24 00:00:00 ET · period of report 2024-01-22 · accession 0001801385-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-24 | 2024-01-22 | KRYS | Romano Kathryn | CAO | M - OptEx | $52.26 | +2,500 | 15.1K | +20% | +$130.7K |
| D | 2024-01-24 | 2024-01-22 | KRYS | Romano Kathryn | CAO | S - Sale+OE | $130.00 | -2,500 | 12.6K | -17% | -$325.0K |
| D | 2024-01-24 | 2024-01-22 | KRYS | Romano Kathryn | CAO | M - OptEx | $0.00 | -2,500 | 10.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-22 | M | A | 2,500 | $52.26 | 15,056 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-22 | S | D | 2,500 | $130.00 | 12,556 | D | — | — | (F2) The transaction was executed in one trade. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-01-22 | M | D | 2,500 | $0.00 | 10,000 | D | $52.26 · — to 2030-01-30 | 2,500 Common Stock | (F3) 50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021. |